-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: Labor-Inducing Drug Associated With 8 Deaths From: Braun, R. Daniel (rbraun@iupui.edu) Fri Dec 22 06:04:59 2000 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: Braun, R. Daniel: "Re: Mother Jones Article" Previous message: Joanne Bulley: "Re: Near Term Twins/Delivery Mode--long reply" And how many do you think there were where Pitocin was used? Dan R. Daniel Braun, MD FACOG Clinical Professor Department of Obstetrics and Gynecology Indiana U. School of Medicine Indianapolis, IN 46202 OBGYN.net International Representative for United States Certified AllExperts Expert Check out my bio/ratings page! http://www.allexperts.com/displayExpert.asp?Expert=1236 -----Original Message----- From: Griffiths Malcolm (RC9) Luton & Dunstable Hospital TR[mailto:Malcolm.Griffiths@ldh-tr.anglox.nhs.uk] Sent: Friday, December 22, 2000 4:00 AM To: Multiple recipients of list OB-GYN-L Subject: Re: Labor-Inducing Drug Associated With 8 Deaths Agreed but eight deaths is still hell of a lot and not something to be dismissed. -----Original Message----- From: Steve & Eryl Raymond [mailto:eryl@intekom.co.za] Sent: 22 December 2000 08:49 To: Multiple recipients of list OB-GYN-L Subject: Re: Labor-Inducing Drug Associated With 8 Deaths Malcolm, it's not the drug, but how it has been used that is the likely cause of the trouble. If you were to use Prostaglandin E2 without due care and attention to the potential complications and to the dose you could have the same scenario. "Griffiths Malcolm (RC9) Luton & Dunstable Hospital TR" wrote: > I would be very concerned if even in a large population such as the USA that > there had been eight deaths associated with induction of labour let alone > form induction of labour by an off-label product only being used by a > minority of ob/gyns. Death seems to me to e a definite end-point and one > that one can't argue with. > > This information would cause me concerns and I would not be so dismissive. > > Subject: Re: Labor-Inducing Drug Associated With 8 Deaths > > >... the drug's > >manufacturer, G.D. Searle Corporation, sent a letter to 200,000 health care > >providers warning them that "Cytotec administration by any route is > >contraindicated in women who are pregnant because it can cause abortion." > >(The drug is, in fact, used in combination with RU-486, for this specific > >purpose.) The company also noted that off-label use of the drug has resulted > >in reports of uterine rupture, hysterectomy, and the death of mothers and > >infants.... > -- Dr. S.H. Raymond Department of Obstetrics & Gynaecology Empangeni Hospital Private Bag X20005 Empangeni South Africa 3880 Ph. (+27) (035) 7721111 Fax (+27) (035) 7922596 ********************************************************************** This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed. If you have received this email in error please notify the system manager. This footnote also confirms that this email message has been swept by MIMEsweeper for the presence of computer viruses. ********************************************************************** Next message: Braun, R. Daniel: "Re: Mother Jones Article" Previous message: Joanne Bulley: "Re: Near Term Twins/Delivery Mode--long reply"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 04:49:01 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.